Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 6, 2022; 10(22): 7890-7898
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7890
Published online Aug 6, 2022. doi: 10.12998/wjcc.v10.i22.7890
Antibiotic and glucocorticoid-induced recapitulated hematological remission in acute myeloid leukemia: A case report and review of literature
Xiao-Yun Sun, Xiao-Dong Yang, Bo Ju, Nuan-Nuan Xiu, Jia Xu, Xi-Chen Zhao, Department of Hematology, The Central Hospital of Qingdao West Coast New Area, Qingdao 266555, Shandong Province, China
Xiao-Qiu Yang, Department of Pharmacology, The Central Hospital of Qingdao West Coast New Area, Qingdao 266555, Shandong Province, China
Author contributions: Sun XY, Yang XD and Yang XQ analyzed the data and drafted the manuscript; Sun XY, Yang XD, Ju B, Xiu NN, Xu J participated in the treatment of this patient; Zhao XC supervised the treatment and finally decided on the manuscript; and all authors have read and approved the final version of the manuscript.
Supported by the Specialized Scientific Research Fund Projects of The Medical Group of Qingdao University , No. YLJT20201002 .
Informed consent statement: Written informed consent was not obtained from the patient.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xi-Chen Zhao, MD, Chief Doctor, Department of Hematology, The Central Hospital of Qingdao West Coast New Area, No. 9 Huangpujiang road, Qingdao 266555, Shandong Province, China. zhaoxichen2003@163.com
Received: August 10, 2021
Peer-review started: August 10, 2021
First decision: October 20, 2021
Revised: October 29, 2021
Accepted: June 24, 2022
Article in press: June 24, 2022
Published online: August 6, 2022
Processing time: 345 Days and 19.7 Hours
Peer-review started: August 10, 2021
First decision: October 20, 2021
Revised: October 29, 2021
Accepted: June 24, 2022
Article in press: June 24, 2022
Published online: August 6, 2022
Processing time: 345 Days and 19.7 Hours
Core Tip
Core Tip: Untreated leukemia patients usually experience an aggressive process. However, spontaneous remission occasionally occurs in a small number of patients with acute myeloid leukemia. Here, we report an acute myeloid leukemia (AML) patient with t(8;21) translocation who achieved recapitulated spontaneous remissions after antibiotic and dexamethasone treatments for febrile episodes and skin lesions. These antibiotic and dexamethasone treatment-induced spontaneous remissions indicated that inflammatory stresses, most likely arising from gastrointestinal infection, sustained the growth and survival advantage of the leukemia cells. Inflammation-sustained proliferation may represent a specific subgroup of AML.